Raj HC: Convicted Minor Gang Rapist Not Fully Barred From Open-Air Camps; Rules Allow Exceptions  ||  Calcutta High Court: Serving a Show-Cause Notice Via Email is Valid under PMLA Regulations  ||  Del HC: Candidate’s Independent Medical Opinions Don’t Justify Fresh Medical Exam in SSC Recruitment  ||  Calcutta HC: Magistrate Must Assess Grounds, Cannot Order Police Inquiry under Section 175(3) BNSS  ||  SC Grants Law Officer Exam Relief, Saying Students Can’t be Blamed When Judges Differ in Views  ||  SC: Fraudulent Diversion of Company Funds Cannot be Validated by Later Shareholder Ratification  ||  SC: Doctor’s View on a Victim’s Consciousness Prevails over Police Assessment in Dying Declarations  ||  SC: Examining Contradictions and Witness Credibility Exceeds the Scope of Section 319 CrPC  ||  Supreme Court Struck Down Section 60(4), Removing Limits on Maternity Benefits For Adoptive Mothers  ||  Supreme Court: Air Force Group Insurance Society qualifies as ‘State’ under Article 12    

Search Results for Tag : diabetes

Judgments

Delhi High Court rules in favour of Merck for its diabetes drug(07.10.2015)

The Delhi High Court restrained Glenmark from selling any drug containing Sitagliptin or its derivate. Sitagliptin is the active ingredient used in ‘J.....

Tags : Glenmark, merck, patent, diabetes



Notifications & Circulars

Dr. Jitendra Singh releases 'Indian Guidelines for Diabetes Management'(09.05.2018)

The Union Minister of State (Independent Charge) of the Ministry of Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances.....

Tags : Guidelines, Diabetes Management, Release



News

Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin”(14.12.2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporatio.....

Tags : Kolkata Patent Office, Patent , Diabetes Drug Teneligliptin



Delhi HC Sets Aside Centre's Ban on FDCs for Type-2 Diabetes(18.02.2019)

Delhi High Court has set aside Centre's notifications banning manufacture and sale of fixed drug combinations (FDCs) used for treatment of Type-2 diab.....

Tags : Delhi High Court, FDCs for Type-2 Diabetes



Disclaimer | Copyright 2026 - All Rights Reserved